Trial Profile
A study comparing the clinical performances of zotarolimus-eluting stents(ZES) and everolimus-eluting stents (EES) in patients with multi-vessel coronary artery disease who underwent percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Feb 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions; Therapeutic Use
- 24 Feb 2016 New trial record